Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Shasun

Strides Shasun

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 30, 13:11
909.20
30.45 (3.47%)
VOLUME 33,281
LIVE
NSE
May 30, 13:12
909.00
29.8 (3.39%)
VOLUME 329,899
News on Strides Shasun
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
3 hot stock picks from Reliance Securities

8.58 am | 29 May 2017 |  Source: Moneycontrol.com

Strides Shasun, Indiabulls Housing Finance & Bajaj Auto are on the radar of Reliance Securities...

Strides Shasun Q4 profit soars multi-fold to Rs 131.90 cr 

5.29 pm | 18 May 2017 |  Source: PTI

Drug firm Strides Shasun today reported multi-fold jump in consolidated net profit to Rs 131.90 crore for the January-March quarter on account of lowe...

Strides Shasun gains on clearing US FDA audit for its Puducherry API plant

3.58 pm | 05 May 2017 |  Source: Moneycontrol.com

Puducherry API plant was inspected from May 1-5. Two other facilities of Strides including its API plant in Cuddalore and oral dosage facility in Pudu...

Strides Shasun: USFDA completes third consecutive inspection with zero 483

2.08 pm | 05 May 2017 |  Source: Moneycontrol.com

Strides Shasun announced that its active pharmaceutical ingredients manufacturing site in Puducherry was recently inspected by USFDA and the approval ...

Strides Shasun gains 1% post zero 483 observations from USFDA

9.31 am | 02 May 2017 |  Source: Moneycontrol.com

The company has successfully completed the inspection with zero 483 observations....

Buy Strides Shasun; target of Rs 1340: Axis Direct

1.52 pm | 20 Feb 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1340 in its research report dated February ...

Border tax counter productive for US, may never happen: Strides 

2.30 pm | 07 Feb 2017 |  Source: CNBC-TV18

Going forward, the pharma company is going to to focus on its B2C business and the high cash generating verticals, he says....

Strides Shasun Q3 profit up 3-fold, divestment income supports

2.46 pm | 03 Feb 2017 |  Source: Moneycontrol.com

Bangalore-based Healthcare firm Strides Shasun has reported a massive 3-fold jump in third quarter consolidated profit at Rs 187.3 crore compared with...

1 2
Quick Links for Strides Shasun
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.